It is important to note that allopurinol and oxypurinol (XO inhibitors) are capable of reversing the impaired eNO production in both heart failure [23-25] and type 2 diabetes mellitus (T2DM) [26]. This evidence concerns the gene XDH and type 2 diabetes mellitus.